Schroder Investment Management Group Repligen Corp Transaction History

Schroder Investment Management Group

$112 Billion
Q2 2025

A detailed history of Schroder Investment Management Group transactions in Repligen Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 206,397 shares of RGEN stock, worth $29.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

206,397

Holding current value

$29.8 Million

% of portfolio

0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$108.89 - $145.23 $22.5 Million - $30 Million	206,397 New	206,397 $25.7 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $257,853 - $327,955	-1,858 Reduced 20.7%	7,117 $1.13 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $1,107 - $1,442	8 Added 0.09%	8,975 $1.27 Million
Q1 2023 May 11, 2023	SELL	$154.26 - $198.1 $670,259 - $860,744	-4,345 Reduced 32.64%	8,967 $1.51 Million
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $82,509 - $112,044	508 Added 3.97%	13,312 $2.25 Million
Q3 2022 Nov 10, 2022	SELL	$160.42 - $256.21 $289,878 - $462,971	-1,807 Reduced 12.37%	12,804 $2.4 Million
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $615,052 - $822,023	-4,372 Reduced 23.03%	14,611 $2.37 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $1.33 Million - $2.12 Million	8,230 Added 76.54%	18,983 $3.58 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $604,614 - $743,515	-2,442 Reduced 18.51%	10,753 $2.85 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $968,396 - $1.61 Million	4,972 Added 60.46%	13,195 $3.81 Million
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $17,416 - $23,199	105 Added 1.29%	8,223 $1.64 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $366,331 - $459,534	2,031 Added 33.37%	8,118 $1.58 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $25.9 Million - $36.2 Million	-175,178 Reduced 96.64%	6,087 $1.17 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $698,429 - $902,297	5,701 Added 3.25%	181,265 $26.8 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $3.6 Million - $5.36 Million	-38,146 Reduced 17.85%	175,564 $21.7 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $2.23 Million - $2.87 Million	-26,254 Reduced 10.94%	213,710 $21.5 Million
Q4 2019 Feb 11, 2020	SELL	$73.84 - $93.08 $734,338 - $925,680	-9,945 Reduced 3.98%	239,964 $22.2 Million
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $1.33 Million - $1.66 Million	-17,386 Reduced 6.5%	249,909 $19.2 Million
Q2 2019 Aug 08, 2019	SELL	$54.2 - $85.95 $670,941 - $1.06 Million	-12,379 Reduced 4.43%	267,295 $23 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $4.1 Million - $5.21 Million	83,004 Added 42.2%	279,674 $16.5 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $3.04 Million - $4.33 Million	-62,908 Reduced 24.23%	196,670 $10.4 Million
Q3 2018 Nov 13, 2018	SELL	$46.8 - $58.97 $10.5 Million - $13.2 Million	-223,649 Reduced 46.28%	259,578 $14.4 Million
Q2 2018 Aug 24, 2018	SELL	$35.26 - $47.04 $5.61 Million - $7.49 Million	-159,227 Reduced 24.78%	483,227 $22.6 Million
Q2 2018 Aug 13, 2018	BUY	$35.26 - $47.04 $4.67 Million - $6.23 Million	132,496 Added 25.98%	642,454 $96.5 Million
Q1 2018 May 11, 2018	BUY	$30.92 - $37.27 $980,627 - $1.18 Million	31,715 Added 6.63%	509,958 $18.5 Million
Q4 2017 Feb 09, 2018	BUY	$32.53 - $38.92 $564,460 - $675,339	17,352 Added 3.76%	478,243 $17.4 Million
Q3 2017 Nov 09, 2017	BUY	$36.98 - $46.06 $17 Million - $21.2 Million	460,891	460,891 $17.4 Million

Others Institutions Holding RGEN

# of Institutions

510

Shares Held

59M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Repligen Corp Transaction History